Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Corcept Therapeutics Inc (NASDAQ: CORT) closed at $68.45 in the last session, up 2.30% from day before closing price of $66.91. In other words, the price has increased by $2.30 from its previous closing price. On the day, 0.72 million shares were traded. CORT stock price reached its highest trading level at $68.93 during the session, while it also had its lowest trading level at $66.79.
Ratios:
We take a closer look at CORT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.29. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 03 ’25 when Maduck Sean sold 20,000 shares for $66.92 per share. The transaction valued at 1,338,400 led to the insider holds 85,318 shares of the business.
Lyon Joseph Douglas sold 5,000 shares of CORT for $334,600 on Feb 03 ’25. The insider now owns 8,759 shares after completing the transaction at $66.92 per share. On Feb 03 ’25, another insider, Maduck Sean, who serves as the Officer of the company, bought 20,000 shares for $66.92 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 7171848192 and an Enterprise Value of 6798312960. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 54.44, and their Forward P/E ratio for the next fiscal year is 35.74. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.41 while its Price-to-Book (P/B) ratio in mrq is 11.22. Its current Enterprise Value per Revenue stands at 10.816 whereas that against EBITDA is 47.182.
Stock Price History:
The Beta on a monthly basis for CORT is 0.59, which has changed by 1.9751 over the last 52 weeks, in comparison to a change of 0.208081 over the same period for the S&P500. Over the past 52 weeks, CORT has reached a high of $71.29, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is 20.16%, while the 200-Day Moving Average is calculated to be 63.98%.
Shares Statistics:
According to the various share statistics, CORT traded on average about 888.84K shares per day over the past 3-months and 1055210 shares per day over the past 10 days. A total of 104.70M shares are outstanding, with a floating share count of 90.11M. Insiders hold about 14.00% of the company’s shares, while institutions hold 81.71% stake in the company. Shares short for CORT as of 1736899200 were 16258254 with a Short Ratio of 18.29, compared to 1734048000 on 15715773. Therefore, it implies a Short% of Shares Outstanding of 16258254 and a Short% of Float of 21.790001.
